The pharma sector received an unexpected boost during the pandemic: an enhanced public image. But maintaining this perception is not an easy task. Now they must demonstrate that their priorities are people, not profits, and deliver long-term value to be appreciated by their stakeholders.
To achieve this, focusing on diversity, equity and inclusion (DEI) is critical, say GEP experts.
Our new white paper, 3 Focus Areas for Pharma Companies to Achieve Greater Diversity, Equity and Inclusion, explains how empowering procurement to drive DEI across three key stakeholder groups — suppliers, workforce and patients — can help pharma companies close the health gap between demographics and allow societies to thrive.
What’s Inside:
- How to ensure entire supply chains meet DEI goals
- Avoiding group think and unconscious bias
- Making sure CROs deliver effectively
This paper is essential reading for pharma procurement and business leaders who want to ensure a clear path toward achieving DEI goals.
Theme: Sustainability
RECOMMENDED
Featured
The Cost-Plus World of Supply Chains: The Macroeconomic and Geopolitical Environment
As geopolitical and macroeconomic concerns increase, this survey-based Economist Impact-GEP report looks at what companies are doing to manage the resultant supply chain challenges.
White Paper
Optimizing Business Outcomes by Investing in Sustainable Supply Chains and Procurement
This GEP-sponsored HBR Analytics Services paper explores how making an organization’s procurement and supply chain efforts greener can drive greater business success.
